NAC (N-Acetylcysteine)

What Is NAC?

N-acetylcysteine (NAC) is an acetylated derivative of the amino acid cysteine and the body’s most important glutathione precursor. Glutathione is the primary endogenous antioxidant—it protects cells from oxidative damage, supports liver detoxification, and plays a key role in immune function.

In clinical medicine, NAC has been established for decades: as the gold-standard antidote for acetaminophen (paracetamol) overdose and as a mucolytic agent for respiratory conditions. In the context of healthy aging, it has gained attention primarily through combination with glycine (GlyNAC).

The GlyNAC Approach to Healthy Aging

Glutathione levels decline substantially with age. The cause is not only cysteine deficiency but also glycine depletion—both amino acids are required for glutathione synthesis. GlyNAC addresses both bottlenecks simultaneously.

The research group of Rajagopal Sekhar at Baylor College of Medicine has conducted the most compelling human studies to date:

• Kumar et al. (2021, n=24 older adults): GlyNAC supplementation (NAC 600 mg + glycine 600 mg, twice daily) for 16 weeks normalized glutathione to young-adult levels, improved mitochondrial function (measured by fatty acid oxidation), reduced oxidative stress (TBARS, F2-isoprostanes), and improved body composition (reduced waist circumference).
• Sekhar (2022, n=24): Follow-up RCT showed improvements in 8 of 9 hallmarks of aging over 24 weeks, including genomic damage, mitochondrial dysfunction, inflammation, and insulin resistance.

Critical limitations:

• All human aging studies come from one research group (Sekhar lab, Baylor). No independent replication exists.
• Sample sizes are very small (n=24 per trial).
• Maximum study duration is 24 weeks. Long-term safety and efficacy are unknown.
• Studies compared GlyNAC to placebo, not to NAC alone or glycine alone—making it difficult to attribute effects to either component.

Beyond Aging: Established and Emerging Uses

Gold-standard clinical use

• Acetaminophen overdose: NAC is the definitive treatment, used in emergency medicine worldwide. Efficacy is unquestioned.
• Mucolytic (respiratory): Oral NAC 600 mg/day reduces mucus viscosity; meta-analyses show reduced exacerbation frequency in chronic bronchitis (Mokhtari et al. 2017).

Psychiatric applications

NAC shows moderate effects in RCTs for psychiatric conditions, including depressive symptoms, OCD, and addictive behaviors. The mechanism involves both glutamatergic modulation and antioxidant effects in the brain (Berk et al. 2013). Evidence is promising but study sizes are often limited.

Glutathione repletion

Oral NAC (600–1,200 mg/day) reliably increases plasma glutathione levels. This is the most robust and reproducible biochemical effect across multiple populations.

What Is NOT Proven

• Lifespan extension in humans
• Cancer prevention (theoretical antioxidant benefit, but no clinical evidence; some concern that antioxidants may theoretically protect tumor cells)
• Cognitive enhancement in healthy adults
• Long-Covid treatment (widely discussed, clinical trials ongoing, no conclusive results as of 2026)

Safety

At 600–1,200 mg/day, NAC is considered likely safe. Common side effects: nausea, vomiting, flatulence (typically mild and transient).

Important warnings:

• Do not combine with nitroglycerin or nitrate medications (additive blood pressure–lowering, potentially dangerous hypotension)
• Asthma patients: NAC can trigger bronchospasm in rare cases
• FDA regulatory status in the US is uncertain (NAC was approved as a drug before it was sold as a supplement; the FDA has considered—but not finalized—restricting supplement sales)
• In the EU, NAC remains legally available as a dietary supplement

Dosage and Practical Use

• Standard supplementation: 600 mg once or twice daily
• GlyNAC protocol (Sekhar studies): 600 mg NAC + 600 mg glycine, twice daily (1,200 mg each per day)
• Mucolytic use: 600 mg/day, well-established dose
• Take on empty stomach or with food: Both approaches used in studies; no strong evidence favoring either

Practical Note

NAC alone is often insufficient for optimal glutathione synthesis. GlyNAC (NAC + glycine in equal amounts) is more effective than NAC alone based on current data—the dual-precursor approach addresses both rate-limiting amino acids.

Summary

NAC has a solid foundation as a glutathione precursor with decades of established clinical use. The GlyNAC research is the most exciting development in the longevity context, but it remains early-stage: small samples, one lab, no independent replication, maximum 24-week follow-up. As a standalone supplement in healthy individuals without specific indications, the benefit is not established. For older adults interested in glutathione optimization, GlyNAC appears more rational than NAC alone—but with the clear caveat that the evidence base is preliminary.